Medical News

Modification of the HEART pathway by adding coronary compute...

Using the CCTA after the HP in selected patients could be a better strategy to discharge more patients early and...

06 Jul 2020

Decreased Duration of Intravenous Cephalosporins in Intensiv...

Within the limitations inherent to our study design, reducing the exposure of prophylactic systemic antibiotics in...

03 Jul 2020

sTREM-1 Predicts Mortality in Hospitalized Patients with Inf...

sTREM-1 predicts mortality from infection in a tropical, middle-income country comparably to a model derived from...

02 Jul 2020

Impact of Duration of Antibiotic Therapy in Central Venous C...

The administration of appropriate antibiotic therapy for ≤7 days may be as safe and effective as longer courses in...

29 Jun 2020

eCMEs

Date: 11th July 2020
Time: 5:00 pm to 6:00 pm
Date: 7th July 2020
Time: 3:00 pm to 4:00 pm
Date: 7th July 2020
Time: 3:00 pm to 4:00 pm

Key Trials

Noninferiority of Ceftriaxone, Sulbactam, and Disodium EDTA to Meropenem in Complicated UTIs

This study demonstrated the noninferiority of the novel combination of ceftriaxone, sulbactam, and disodium ethylenediaminetetraacetic acid (CSE) to...

Efficacy of High Dose Minocycline against Carbapenem Resistant Gram Negative Bacilli

In the era of increasing resistance to antibiotics, high dose of minocycline plays a pivotal role in managing gram negative bacilli. The need for...

Indian Prospective Study Comparing the Nephrotoxicity of Colistin and Polymyxin B Administered in Currently Recommended Doses

Polymyxins have been associated with a risk of nephrotoxicity. Different studies have evaluated the toxicity of polymyxins and have demonstrated a...

GLIMP Study: Worldwide Prevalence and Risk Factors for MRSA Pneumonia

The Global Initiative for MRSA Pneumonia (GLIMP) study, is an international, multicenter study aimed to determine the point prevalence and specific...

Slide Library

Cefuroxime (Novacef)

Cefuroxime is a second-generation cephalosporin antibiotic. It is a broad-spectrum antibacterial agent with a favorable pharmacokinetic profile....

 
Email this page
Management of Mucormycosis in ENT Practice

Mucormycosis are the group of invasive infection caused by filamentous fungi of the Mucoraceae family. This slide set enumerates prevalence,...

 
Email this page
Antifungal Therapy in Immunocompromised Patients

Early initiation of antifungal therapy is a major contributor to enhanced survival rate. This set of slides highlights incidence and risk factors of...

 
Email this page
Disseminated Tuberculosis with ARDS

Disseminated TB results from widespread blood borne dissemination of TB bacilli. This presentation includes causes and risk factors of disseminated...

 
Email this page

Our Publications

Cytorx (Flucytosine) Monograph

This monograph describes the role of Flucytosine tablets in the management of invasive cryptococcal infections and some Candida spp. infections.  

Clarithromycin: An Emerging Treatment Recourse in Lower Respiratory Tract Infections

Parenteral macrolide therapy is needed for patients with moderate to severe CAP/AECB. This booklet gives an overview of the efficacy and safety of...

MRSA: The Clinician’s Challenge

The article summarizes the Indian epidemiological data for MRSA infections, along with treatment of MRSA infections and infection control measures.

Phosome IV (Liposomal Amphotericin B) Monograph

Amphotericin B deoxycholate has a broad antifungal activity, and today it is the best antifungal available against most systemic fungal infections,...

Poll

Do you perceive any clinical benefits of neurotrophic agent in the management of acute brain injury?
Yes
25% (2 votes)
Sometimes
25% (2 votes)
No
50% (4 votes)
Total votes: 8